Evidence map›Paper›PMID 24521217›Full record

ArticleDiabetes, obesity & metabolism2014

Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.

B Vandanmagsar, K R Haynie, S E Wicks, E M Bermudez, T M Mendoza, D Ribnicky, W T Cefalu, R L Mynatt

Open access · greenAbstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Research progress on the effects of adverse exposure during pregnancy on skeletal muscle function in the offspring.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Review
  2. Extract ofInternational journal of molecular sciences · 2023
    Article
  3. Review
  4. Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. An Extract ofOxidative medicine and cellular longevity · 2018
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Aqueous and alcoholic extracts ofAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

B VandanmagsarGene Nutrient Interactions Laboratory, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA.
K R Haynie
S E Wicks
E M Bermudez
T M Mendoza
D Ribnicky
W T Cefalu
R L Mynatt
Pennington Biomedical Research Center · USLouisiana State University System · USRutgers, The State University of New Jersey · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RASKIN, ILYA · 2005 to 2019
$24.9M
Mentoring Obesity and Diabetes Research in LouisianaP20GM103528 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2012 to 2015
$8.8M
Molecular Genetics of ThermogenesisR01DK089641 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MYNATT, RANDALL LEE, YOUNG, MARTIN E · 2010 to 2013
$1.6M
Inhibition of CPT-1b in muscle: effects on glucose homeostasisR01DK098687 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MYNATT, RANDALL LEE · 2013 to 2017
$1.6M
NCCIH NIH HHS P50 AT002776NCCIH NIH HHS P50AT002776NIDDK NIH HHS 2P30-DK072476NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK089641NIDDK NIH HHS R01DK089641NIDDK NIH HHS R01 DK098687NIGMS NIH HHS 8P20GM103528NIGMS NIH HHS P20 GM103528
6 · The paper itself

Abstract

aimsBioactives of Artemisia dracunculus L. (termed PMI 5011) have been shown to improve insulin action by increasing insulin signalling in skeletal muscle. However, it was not known if PMI 5011's effects are retained during an inflammatory condition. We examined the attenuation of insulin action and whether PMI 5011 enhances insulin signalling in the inflammatory environment with elevated cytokines.

methodsMuscle cell cultures derived from lean, overweight and diabetic-obese subjects were used. Expression of pro-inflammatory genes and inflammatory response of human myotubes were evaluated by real-time polymerase chain reaction (RT-PCR). Insulin signalling and activation of inflammatory pathways in human myotubes were evaluated by multiplex protein assays.

resultsWe found increased gene expression of monocyte chemoattractant protein 1 (MCP1) and TNFα (tumour necrosis factor alpha), and basal activity of the NFkB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway in myotubes derived from diabetic-obese subjects as compared with myotubes derived from normal-lean subjects. In line with this, basal Akt phosphorylation (Ser473) was significantly higher, while insulin-stimulated phosphorylation of Akt (Ser473) was lower in myotubes from normal-overweight and diabetic-obese subjects compared with normal-lean subjects. PMI 5011 treatment reduced basal phosphorylation of Akt and enhanced insulin-stimulated phosphorylation of Akt in the presence of cytokines in human myotubes. PMI 5011 treatment led to an inhibition of cytokine-induced activation of inflammatory signalling pathways such as Erk1/2 and IkBα (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha)-NFkB and moreover, NFkB target gene expression, possibly by preventing further propagation of the inflammatory response within muscle tissue.

conclusionsPMI 5011 improved insulin sensitivity in diabetic-obese myotubes to the level of normal-lean myotubes despite the presence of pro-inflammatory cytokines.

Indexed as

Insulin ResistanceAnti-Inflammatory Agents, Non-SteroidalAnti-Obesity AgentsArtemisiaBody Mass IndexCells, CulturedCytokinesDiabetes ComplicationsGene Expression RegulationHumansHypoglycemic AgentsMuscle Fibers, SkeletalObesityOverweightPhosphorylationPlant ExtractsAKT1 protein, humanAnti-Inflammatory Agents, Non-SteroidalAnti-Obesity AgentsCytokinesHypoglycemic AgentsPlant ExtractsPMI-5011Proto-Oncogene Proteins c-aktAktArtemisia dracunculus Lchemokinescytokinescytokine signalingErk1/2IkBαIL6insulin resistanceinsulin signalingIRS1NFkBPMI 5011skeletal muscle inflammationTNF

Identifiers

PMID24521217
PMCPMC4107009
OpenAlexW1495043182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.